HomeNewsBusinessIndiGo Q2 results | Traffic, revenue are increasing but so are the costs
Trending Topics

IndiGo Q2 results | Traffic, revenue are increasing but so are the costs

Fuel accounted for 27 percent of the total costs in the September quarter. As a lot of expenses are dollar-denominated, a further slide in the rupee will hurt the airline more

October 28, 2021 / 19:44 IST
Story continues below Advertisement
IndiGo losses narrowed to Rs 1,440 crore in Q2 as recovery gathered pace.
IndiGo losses narrowed to Rs 1,440 crore in Q2 as recovery gathered pace.

India's biggest domestic carrier IndiGo reported a loss of Rs 1,435.6 crore in the September quarter, translating to losing Rs 15.77 crore a day. This is less than half of what it was in the first quarter when the country experienced its worst spike in COVID-19 cases.

The airline has stayed away from projecting future loads or capacity in the last few quarters. But when it announced its September quarter numbers on October 28, the airline gave an indication that its projected load factor for the month could be around 76 percent.

Story continues below Advertisement

There is a significant improvement in the revenue side, with traffic coming back and also revenue coming in from cargo operations.

Surprising as it may seem, booked revenue for October is the same as that for January 2020, which was pre-COVID. What is surprising and interesting is that it comes at a 20 percent lower capacity than January 2020.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show